Product Reports Resources Pricing Login Book a demo

Isomorphic Labs

Biotech & Life Sciences · London, United Kingdom · Founded 2021

Isomorphic Labs, founded in 2021, is an AI-driven company dedicated to revolutionizing drug discovery and development. By leveraging the groundbreaking advancements from Google DeepMind, such as AlphaFold, Isomorphic Labs aims to apply machine learning and computational methods to tackle complex biological challenges. The company operates at the intersection of AI, biotechnology, and medicine, focusing on developing predictive and generative models to enhance the efficiency and effectiveness of drug design and medical research. Supported by the robust infrastructure of Alphabet Inc., Isomorphic Labs combines the agility of a startup with substantial resources and expertise. The leadership team, including notable figures like Sir Demis Hassabis and Colin Murdoch, drives the company's mission to transform how medicine is discovered and delivered. Their approach integrates deep learning, reinforcement learning, and other advanced AI techniques to innovate within the life sciences, aiming to bring better therapeutic solutions to market more swiftly and accurately.

Investors

8 investors on Isomorphic Labs's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 5 investors entered at this stage
Series B+ 3 investors entered at this stage
Google DeepMind
Thrive Capital
GV

Global footprint

Where Isomorphic Labs has talent and traffic

Workforce by country
6 countries with
team presence
🇬🇧 United Kingdom87.1%
🇨🇭 Switzerland9.4%
🇺🇸 United States2.4%
🇨🇦 Canada0.6%
🇮🇹 Italy0.3%
Top 5 of 6 shown
Web traffic by country
130K monthly visits
across markets
🇺🇸 United States17.2%
🇬🇧 United Kingdom14.5%
🇮🇳 India10.5%
🇨🇦 Canada4.2%
🇧🇩 Bangladesh3.9%
Top 5 markets shown

Talent graph

The shape of Isomorphic Labs's talent

Dealroom maps Isomorphic Labs's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

71 standout operatorsDealroom-flagged across the org
51 AI specialistsincl. 47 core researchers
408 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Isomorphic Labs's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$91k patent portfolio · 9 active families

Estimated portfolio value
$91k
<0.01% of valuation · 257.3× smaller than top peer Recursion Pharma ($23M)
9 active patent families

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Isomorphic Labs

An AI-synthesized read of the highest-engagement posts about Isomorphic Labs on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Isomorphic Labs on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.